Primary Record
Tachyplesin I
- In stock
- 5,494 g
- Purity
- 99.3 %
- CAS
- 118231-04-2
Compound Identifiers & Properties
- CAS
- 118231-04-2
- PubChem CID
- 16129721
- SMILES
- CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CC4=CC=C(C=C4)O)CCCNC(=N)N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCCN)N)CC7=CC=CC=C7)CCCNC(=N)N)C(C)C
- Canonical SMILES
- CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)CSSC[C@H](NC(=O)[C@H](Cc1c[nH]c3ccccc13)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N2
Names & Synonyms
- Tachyplesin I
- Tachyplesin
- RGD-tachyplesin
- Tachyplesin I (9CI)
- KWCFRVCYRGICYRRCR-NH2
- RefChem:187112
- 118231-04-2
- TAC1_CARRO Tachyplesin-1
- Lipopolysaccharide-binding peptide
- Tachyplesin I Trifluoroacetate
- orb2277440
- CHEMBL4544197
- SCHEMBL29353475
- tachyplesin peptide, Tachypleus tridentatus
- Tachyplesin I trifluoroacetate salt
- HY-P1632
- MFCD22681513
- Tachyplesin I (Tachypleus tridentatus)
- BAT-010919
- BAT-015165
- DA-58240
- FT108379
- LS-186881
- LS-187536
- CS-0065054
- (1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-10-benzyl-33-[(2S)-butan-2-yl]-7,21,24,39-tetrakis(3-carbamimidamidopropyl)-13-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-27,42-bis[(4-hydroxyphenyl)methyl]-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecaoxo-4-propan-2-yl-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo[28.14.4]octatetracontane-18-carboxamide
- A1110595
- Tachyplesin I (reduced), cyclic (3.16),(7.12)-bis(disulfide)
- H-Lys-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Ile-Cys-Tyr-Arg-Arg-Cys-Arg-NH2
- (1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-10-benzyl-33-((2S)-butan-2-yl)-N-((2S)-5-carbamimidamido-1-hydroxy-1-iminopentan-2-yl)-7,21,24,39-tetrakis(3-carbamimidamidopropyl)-13-(((2S)-2-(((2S)-2,6-diamino-1-hydroxyhexylidene)amino)-1-hydroxy-3-(1H-indol-3-yl)propylidene)amino)-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecahydroxy-27,42-bis((4-hydroxyphenyl)methyl)-4-propan-2-yl-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo(28.14.4)octatetraconta-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecaene-18-carboximidic acid
- (1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-10-benzyl-N-[(1S)-1-carbamoyl-4-guanidino-butyl]-13-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-7,21,24,39-tetrakis(3-guanidinopropyl)-27,42-bis[(4-hydroxyphenyl)methyl]-4-isopropyl-33-[(1S)-1-methylpropyl]-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecaoxo-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo[28.14.4]octatetracontane-18-carboxamide
- (1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-N-((2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl)-10-benzyl-33-((2S)-butan-2-yl)-7,21,24,39-tetrakis(3-carbamimidamidopropyl)-13-(((2S)-2-(((2S)-2,6-diaminohexanoyl)amino)-3-(1H-indol-3-yl)propanoyl)amino)-27,42-bis((4-hydroxyphenyl)methyl)-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecaoxo-4-propan-2-yl-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo(28.14.4)octatetracontane-18-carboxamide
- H-Lys-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Ile-Cys-Tyr-Arg-Arg-Cys-Arg-NH2 (Disulfide bridge: Cys3-Cys16, Cys7-Cys12)
- NH2-Lys-Trp-Cys(x2)-Phe-Arg-Val-Cys(x1)-Tyr-Arg-Gly-Ile-Cys(x1)-Tyr-Arg-Arg-Cys(x2)-Arg-NH2
- TPI